Role of Organic Osmolytes in Renal Papillary Necrosis

有机渗透剂在肾乳头坏死中的作用

• 批准号: 7244260
• 负责人: GILBERT WOLFRAM MOECKEL
• 金额: $ 11.86万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-07-15 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7244260
• 关键词: Abbreviations; Address; Adenoviruses; Affect; Aldehyde Reductase; Analgesics; Animal Model; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Apoptosis; Apoptotic; Aspirin; Betaine; Canis familiaris; Cell Death; Cells; Condition; Consumption; Coxibs; Data; Dehydration; Development; Diagnostic Procedure; Dominant-Negative Mutation; Enhancers; Enzymes; Etiology; GABA transporter; Gene Expression; Genes; Glycerylphosphorylcholine; Goals; Health; High Pressure Liquid Chromatography; Human; I-kappa B Proteins; Impairment; In Vitro; Induction of Apoptosis; Ingestion; Injury; Inositol; Kidney; Kidney Diseases; Lead; Lesion; Link; Measures; Mediating; Mitochondria; Modeling; Molecular; Morbidity - disease rate; Mus; Necrosis; Non-Prescription Drugs; Non-Steroidal Anti-Inflammatory Agents; Nuclear; PTGS2 gene; Papillary; Pathologic; Pathway interactions; Patients; Peroxisome Proliferator-Activated Receptors; Pharmaceutical Preparations; Preventive; Process; Property; Prostaglandin-Endoperoxide Synthase; Prostaglandins; Protein Isoforms; Public Health; Regulation; Reporting; Research; Role; Signal Transduction; Societies; Sodium; Sorbitol; Stress; System; Testing; Therapeutic; Transcriptional Activation; Transcriptional Regulation; Tumor Necrosis Factor Ligand Superfamily Member 6; Urea; Work; activating transcription factor; base; cell injury; cofactor; cyclooxygenase 1; cyclooxygenase 2; design; diabetic; enhancer binding protein; in vivo; inhibitor/antagonist; insight; interstitial cell; kidney cell; mortality; multicatalytic endopeptidase complex; mutant; polyol; progesterone 11-hemisuccinate-(2-iodohistamine); response; trimethylamine

DESCRIPTION (provided by applicant): Analgesic nephropathy is an important public health problem in many Western societies. The use of analgesic and non-steroidal anti-inflammatory drugs (NSAIDs) is increasing. The ingestion of these agents, particularly NSAIDs, has been associated with significant morbidity and mortality. Renal Papillary Necrosis (RPN), the hallmark lesion of analgesic nephropathy, is a pathologic entity that is still poorly understood despite intensive research. The long-term goal of the proposed studies is to elucidate the pathologic mechanisms involved in RPN at the molecular level. We hypothesize that COX2 inhibitors (i.e. analgesics and NSAIDs) contribute to renal medullary cell death under hypertonic conditions through impairment of organic osmolyte accumulation. Our hypothesis is based on our exciting in vivo and in vitro data that show reduction of intracellular osmolyte concentrations in medullary kidney cells by COX2 inhibition and rescue of COX2 inhibitor-mediated apoptosis by osmolytes. Our hypothesis will be tested by examining the impact of COX2 inhibition on transcriptional regulation of osmolyte genes and osmolyte transporter activities in cultured mouse medullary interstitial cells (mMICs) under hypertonic conditions, as well as in mouse medullary kidney cells under dehydration in vivo (specific aim 1). We will then progress to investigate in the same model the induction mechanisms of apoptosis by COX2 inhibition and the antiapoptotic properties of organic osmolytes (specific aim 2). Finally, the role of cell signaling and nuclear signaling mechanisms involved in COX2- dependent survival mechanisms and regulation of osmolyte accumulation in mMICs will be defined (specific aim 3). RPN is a pathologic entity that is still poorly understood. The studies in this proposal address this major gap in our understanding of RPN. Our long-term goals are to gain insight into mechanistic processes that lead to this important health problem. It is necessary to understand these processes in order to design effective diagnostic procedures, therapeutic approaches and preventive measures for RPN.

描述（由申请人提供）： 在许多西方社会，镇痛剂肾病是一个重要的公共卫生问题。镇痛药和非甾体抗炎药（NSAID）的使用正在增加。摄入这些药物，特别是NSAID，与显著的发病率和死亡率相关。肾乳头坏死（RPN）是镇痛剂肾病的标志性病变，尽管进行了深入的研究，但其病理学性质仍知之甚少。本研究的长期目标是在分子水平上阐明RPN的病理机制。我们假设COX2抑制剂（即镇痛药和NSAID）通过损害有机渗透压物质的积累，在高渗条件下导致肾髓质细胞死亡。我们的假设是基于我们令人兴奋的体内和体外数据，这些数据显示通过COX 2抑制和通过渗透剂拯救COX 2转运蛋白介导的细胞凋亡来降低髓质肾细胞中的细胞内渗透剂浓度。我们的假设将通过检查COX2抑制对高渗条件下培养的小鼠髓质间质细胞（mMIC）以及体内脱水条件下小鼠髓质肾细胞中渗透压因子基因转录调控和渗透压因子转运蛋白活性的影响来进行检验（具体目的1）。然后，我们将在相同的模型中研究通过COX 2抑制诱导细胞凋亡的机制和有机渗透剂的抗细胞凋亡特性（具体目标2）。最后，将定义参与COX 2依赖性存活机制和mMIC中渗透压累积调节的细胞信号传导和核信号传导机制的作用（具体目标3）。RPN是一种病理实体，仍然知之甚少。本提案中的研究解决了我们对RPN理解中的这一主要差距。我们的长期目标是深入了解导致这一重要健康问题的机械过程。有必要了解这些过程，以设计有效的诊断程序，治疗方法和预防措施的RPN。

项目成果

A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.

一名患有慢性丙型肝炎感染和肾病综合征的女性，在干扰素α治疗后出现多发性肾脏病变。

• 发表时间: 2004
• 期刊: American journal of kidney diseases : the official journal of the National Kidney Foundation.
• 作者: Fisher,MaxwellE;Rossini,Michele;Simmons,Edith;Harris,RaymondC;Moeckel,Gilbert;Zent,Roy
• 通讯作者: Zent,Roy